Comparative antagonistic activity of probiotic Lactobacillus and Bacillus strains against oral Candida isolates: insights into cell-free supernatant and viable cell-mediated interactions
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20260777Keywords:
Probiotics, Bacillus, Lactobacillus, Oral Candida, Cell- free supernatant, Antimicrobial resistanceAbstract
Background: Candida species represent a diverse group of opportunistic yeasts, including clinically important taxa with exhibiting emerging antifungal resistance, complicating the management of oral candidiasis. Probiotic Lactobacillus and Bacillus have emerged as promising adjunctive or alternative agents for controlling oral Candida through antimicrobial metabolite production and competitive interactions.
Methods: The antagonistic activity of four commercial Bacillus strains (B. subtilis, B. coagulans, B. clausii, B. mesentericus) and three Lactobacillus strains (L. acidophilus, L. rhamnosus, L. reuteri) was assessed against 160 oral Candida isolates (C. albicans, C. tropicalis, Pichia kudriavzevii, C. parapsilosis). Agar overlay, agar well diffusion and spot assays were conducted to compare the inhibitory potency of viable probiotic cells and their cell-free supernatants.
Results: B. coagulans and B. subtilis demonstrated the greatest inhibitory effects across multiple Candida species, followed by notable inhibition from L. acidophilus, L. rhamnosus and L. reuteri. Viable probiotic cells consistently produced zones of inhibition surpassing those observed with cell-free supernatants, highlighting the importance of direct microbial presence and contact in antagonism.
Conclusions: The study establishes that probiotic antagonism against oral Candida is largely strain-specific and dependent on assay conditions, with active cellular interactions playing a crucial role. The findings support the therapeutic potential of viable Bacillus and Lactobacillus preparations as biotherapeutic agents in the prevention and management of oral candidiasis.
Metrics
References
Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: a review of recommendations for detection and control in health care settings. J Fungi. 2019;5:111. DOI: https://doi.org/10.3390/jof5040111
Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. DOI: https://doi.org/10.1038/nrdp.2018.26
Cao J, Yu Z, Liu W, Zhao J, Zhang H, Zhai Q, et al. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases. J Funct Foods. 2020;64:103643. DOI: https://doi.org/10.1016/j.jff.2019.103643
Lee SH, Kim YJ. A comparative study of the effect of probiotics on cariogenic biofilm model for preventing dental caries. Arch Microbiol. 2014;196:601-9. DOI: https://doi.org/10.1007/s00203-014-0998-7
Bizzini B, Pizzo G, Scapagnini G, Nuzzo D, Vasto S. Probiotics and oral health. Curr Pharm Des. 2012;18:5522-31. DOI: https://doi.org/10.2174/138161212803307473
Hanson L, Vandevusse L, Duster M, Warrack S, Safdar N. Feasibility of oral prenatal probiotics against maternal group B Streptococcus vaginal and rectal colonization. J Obstet Gynecol Neonatal Nurs. 2014;43:294-304. DOI: https://doi.org/10.1111/1552-6909.12308
Gupta RS, Patel S, Saini N, Chen S. Robust demarcation of 17 distinct Bacillus species clades, proposed as novel Bacillaceae genera, by phylogenomics and comparative genomic analyses: description of Robertmurraya kyonggiensis sp. nov. and proposal for an emended genus Bacillus limiting it only to the members of the Subtilis and Cereus clades of species. Int J Syst Evol Microbiol. 2020;70(11):5753-98. DOI: https://doi.org/10.1099/ijsem.0.004475
Joshi A, Thite S, Karodi P, Joseph N, Lodha T. Alkalihalobacterium elongatum gen. nov., sp. nov.: an antibiotic-producing bacterium isolated from Lonar Lake and reclassification of the genus Alkalihalobacillus into seven novel genera. Front Microbiol. 2021;12:722369. DOI: https://doi.org/10.3389/fmicb.2021.722369
Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P, et al. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 2020;70(4):2782-58. DOI: https://doi.org/10.1099/ijsem.0.004107
Fleming HP, Etchells JL, Costilow RN. Microbial inhibition by an isolate of Pediococcus from cucumber brines. Appl Microbiol. 1975;30(6):1040-2. DOI: https://doi.org/10.1128/am.30.6.1040-1042.1975
Nalawade TM, Bhat KG, Sogi S. Antimicrobial Activity of Endodontic Medicaments and Vehicles using Agar Well Diffusion Method on Facultative and Obligate Anaerobes. Int J Clin Pediatr Dent. 2016;9(4):335-41. DOI: https://doi.org/10.5005/jp-journals-10005-1388
Sudan S, Flick R, Nong L, Li J. Potential probiotic Bacillus subtilis isolated from a novel niche exhibits broad-range antibacterial activity and causes virulence and metabolic dysregulation in enterotoxic Escherichia coli. Microorganisms. 2021;9(7):1483. DOI: https://doi.org/10.3390/microorganisms9071483
Castelo-Branco DSCM, Nobre JA, Souza PRH, Diógenes EM, Guedes GMM, Mesquita FP, et al. Role of Brazilian bats in the epidemiological cycle of potentially zoonotic pathogens. Microb Pathog. 2023;177:106032. DOI: https://doi.org/10.1016/j.micpath.2023.106032
Mavor AL, Thewes S, Hube B. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets. 2005;6(8):863-74. DOI: https://doi.org/10.2174/138945005774912735
Barchiesi F, Calabrese D, Sanglard D, Falconi Di Francesco L, Caselli F, Giannini D, et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother. 2000;44(6):1578-84. DOI: https://doi.org/10.1128/AAC.44.6.1578-1584.2000
Paul S, Singh S, Sharma D, Chakrabarti A, Rudramurthy SM, Ghosh AK. Dynamicsof in vitro development of azole resistance in Candida tropicalis. J Global Antimicrob Resist. 2020;22:553-61. DOI: https://doi.org/10.1016/j.jgar.2020.04.018
Wang Y, Yang Q, Chen L, Liu L, Hao R, Zhang T, et al. Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study. Eur J Clin Microbiol Infect Dis. 2017;36(11):2117-26. DOI: https://doi.org/10.1007/s10096-017-3034-4
Zhao C, Lv X, Fu J, He C, Hua H, Yan Z. In vitro inhibitory activity of probiotic products against oral Candida species. J Appl Microbiol. 2016;121(3):785-92. DOI: https://doi.org/10.1111/jam.13138
Gharieb MM, Eid AM, Tihy M. Anticandidal activity of a wild Bacillus subtilis NAM against clinical isolates of pathogenic Candida albicans. Ann Microbiol. 2024;74(1):38. DOI: https://doi.org/10.1186/s13213-024-01764-9
Spaggiari L, Ardizzoni A, Pedretti N, Iseppi R, Sabia C, Russo R, et al. Bacillus coagulans LMG S-24828 impairs Candida virulence and protects vaginal epithelial cells against Candida infection in vitro. Microorganisms. 2024;12:1634. DOI: https://doi.org/10.3390/microorganisms12081634
Salari S, Ghasemi Nejad Almani P. Antifungal effects of Lactobacillus acidophilus and Lactobacillus plantarum against different oral Candida species isolated from HIV/ AIDS patients: an in vitro study. J Oral Microbiol. 2020;12(1):1769386. DOI: https://doi.org/10.1080/20002297.2020.1769386
Jiang Q, Stamatova I, Kari K, Meurman JH. Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions. Benef Microbes. 2015;5(3):1-8. DOI: https://doi.org/10.3920/BM2014.0054
Scillato M, Spitale A, Mongelli G, Privitera GF, Mangano K, Cianci A, et al. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens. Microbiologyopen. 2021;10(2):e1173. DOI: https://doi.org/10.1002/mbo3.1173
Downloads
Published
How to Cite
Issue
Section
